(2002). Predicting functional outcome and survival after acute ischemic stroke.
(2001). Predictors of good outcome after intravenous t-PA for acute ischemic stroke.
(1998). Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II).
(1992). Recombinant intravenous plasminogen activitor in acute thrombotic and embolic stroke. Ann Neurol, 32:78–86. European Stroke Initiative recommendations for stroke management.
(1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Non-interventional Therapy in Ischemic Stroke.
(1999). Stroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis?
(1995). The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
(1999). Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.
(2002). Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature.
(1998). Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
(2001). Thrombolytic therapy for ischemic stroke – a review. Part I – Intravenous thrombolysis. Crit Care Med,
(2001). Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke.
(1989). Vascular Health and Risk Management 2007:3(5) 754 Caso et al
(1999). World Health Organization -International Society of Hypertension Guidelines for the Management of Hypertension.